Difference between revisions of "Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5 (Q9833)"
Jump to navigation
Jump to search
(Created claim: Second Author string (P150): Canalis E, #quickstatements; #temporary_batch_1589998140706) |
(Created claim: DOI Identifier (P138): 10.1210/er.2016-1002, #quickstatements; #temporary_batch_1590000649558) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1210/er.2016-1002 / rank | |||
| + | Normal rank | ||
Revision as of 19:03, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zanotti S
0 references
Canalis E
0 references
